MARKET

NSPR

NSPR

Inspiremd
NASDAQ
3.270
-0.060
-1.80%
After Hours: 3.200 -0.07 -2.14% 19:43 09/29 EDT
OPEN
3.271
PREV CLOSE
3.330
HIGH
3.360
LOW
3.250
VOLUME
14.52K
TURNOVER
0
52 WEEK HIGH
3.770
52 WEEK LOW
0.8064
MARKET CAP
69.31M
P/E (TTM)
-1.6791
1D
5D
1M
3M
1Y
5Y
Piper Sandler Remains a Buy on InspireMD (NSPR)
TipRanks · 09/25 10:55
Weekly Report: what happened at NSPR last week (0918-0922)?
Weekly Report · 09/25 10:38
Weekly Report: what happened at NSPR last week (0911-0915)?
Weekly Report · 09/18 10:34
Weekly Report: what happened at NSPR last week (0904-0908)?
Weekly Report · 09/11 10:33
Weekly Report: what happened at NSPR last week (0828-0901)?
Weekly Report · 09/04 21:16
InspireMD Announces Abstract Of 30-Day Results From The C-Guardians U.S. Investigational Device Exemption Clinical Trial Accepted for Presentation at VIVA23
Benzinga · 08/31 12:07
Weekly Report: what happened at NSPR last week (0821-0825)?
Weekly Report · 08/28 10:38
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 08/23 21:32
More
About NSPR
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Webull offers kinds of InspireMD Inc stock information, including NASDAQ:NSPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSPR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NSPR stock methods without spending real money on the virtual paper trading platform.